today: A quiet start is likely for Indian equities on Monday amid weak global cues and subdued foreign flows. At 7:25 am, the SGX Nifty stood at 18,549 levels, down 53 points than the spot Nifty’s close on Friday.

This week, a slew of macro announcements and US Federal Reserve’s interest rate decision will steer market sentiments. That apart, rupee movement, crude oil prices, and foreign flows will be other important factors.

Meanwhile, here’s a list of stocks that may see action in Monday’s trade:

Glenmark Pharma: The US health regulator issued warning letter for the drugmaker Glenmark Pharmaceuticals for manufacturing lapses at its Goa-based plant. The USFDA flagged off several lapses at the company’s Bardez-based facility in Goa, which produces drug formulations and said that it violates Current Good Manufacturing Practice (CGMP) regulations. READ MORE

Jaiprakash Associates: The company has called a board meeting on Monday, December 12, to mull over sale of their Nilgrie cement unit in Madhya Pradesh. According to reports, Dalmia Cement is the frontrunner in the race to acquire the company, with the Adani Group and Aditya Birla Group also in the fray. READ MORE

NDTV: The board approved proposal to invite RRPR Holding, which is an indirect subsidiary of Adani Enterprises and holds 29.18 per cent in NDTV, to nominate two directors on its board. The appointment of directors would be taken up at their next board meeting scheduled on December 23. READ MORE

Mahindra Holidays: The company plans to invest up to Rs 1,500 crore in the next three years in expansion, which includes room additions and resort acquisitions. That apart, the company will also consider launching a new upscale brand for managing resorts in order to grow its Club Mahindra memberships. READ MORE

Lupin: The drug major is set to enter the digital healthcare space in India with the launch of cardio-vascular therapeutics in 10 cities by February. The development comes after the firm announced its entry into the digital space in June 2021, and involves the creation a new subsidiary, Lupin Digital Health. READ MORE

NTPC: The state-owned firm commenced commercial operation of its solar photo-voltaic project in Tamil Nadu. With this, the standalone installed and commercial capacity of NTPC has become 57,801.27 megawatt (MW), whereas the group’s grew to 70,416.27 MW.